SOURCE: NeuroScience, Inc.

NeuroScience, Inc.

February 01, 2010 11:59 ET

NeuroScience, Inc. Announces the NEI Testing Protocol as Third Entrant in Medical Arsenal for NEI Supersystem Testing and Product Protocols

OSCEOLA, WI--(Marketwire - February 1, 2010) - NeuroScience, Inc. (, the leader in Neuro-Endo-Immune solutions, announces the availability of the Neuro-Endo-Immune (NEI) Testing Protocol. This protocol is designed to assist healthcare practitioners in rapidly identifying the potential root causes of clinical complaints, while treating patients to achieve symptom relief.

Historically, neurology, endocrinology, and immunology were considered three different disciplines. However, current research suggests they are actually part of one, integrated NEI Supersystem©, linked by their respective biochemical messengers: neurotransmitters, hormones, and cytokines. Optimal functioning requires these NEI messengers to be in balance.

NeuroScience, Inc. has developed the NEI Testing Protocol to help healthcare practitioners rapidly identify the root causes of their patients' conditions. This protocol provides a simple, three-step testing algorithm that can be customized based upon a patient's symptoms and history. Step one provides a screen for an active immune response with three chemokines (chemoattractant cytokines), while assessing patients' neurotransmitter and hormone levels. Based on these results, the healthcare practitioner learns if the patient has an elevated immune response and decides if further testing is warranted. Step two is suggested for those patients with an elevated immune response and probable inflammation. This test utilizes stimulated cytokine analysis to provide test results that offer guidance and direction in identifying the probable root causes of the inflammation. Step three in the NEI Testing Protocol includes tests to identify the probable root causes of a patient's elevated immune response. For optimal health, it is imperative that the underlying root causes be identified and addressed. To learn more about the NEI Testing Protocol visit

About NeuroScience, Inc.

NeuroScience, Inc, established in 1999, is a privately held company devoted to medical solutions that improve health by providing esoteric and specialty laboratory testing and products in the clinical segment of neuroendocrine immunology (NEI). The company is research and education focused and provides services world-wide. NeuroScience, Inc. is committed to bringing the most reliable, affordable, nervous system-based interventions to every healthcare practitioner's office as standard of care.

Contact Information